BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27074440)

  • 1. Factor XII in Hemostasis and Thrombosis: Active Player or (Innocent) Bystander?
    Danese E; Montagnana M; Lippi G
    Semin Thromb Hemost; 2016 Sep; 42(6):682-8. PubMed ID: 27074440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
    Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
    J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo roles of factor XII.
    Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
    Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
    Renné T; Nieswandt B; Gailani D
    Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
    Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
    Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
    Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
    Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
    Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.
    Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T
    Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
    Schousboe I
    Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood coagulation factor XII--a neglected player in stroke pathophysiology.
    Pham M; Stoll G; Nieswandt B; Bendszus M; Kleinschnitz C
    J Mol Med (Berl); 2012 Feb; 90(2):119-26. PubMed ID: 21909687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII: form determines function.
    de Maat S; Maas C
    J Thromb Haemost; 2016 Aug; 14(8):1498-506. PubMed ID: 27282310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
    Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic potential of the contact activation pathway.
    Schmaier AH
    Curr Opin Hematol; 2016 Sep; 23(5):445-52. PubMed ID: 27380557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XII full and partial null in rat confers robust antithrombotic efficacy with no bleeding.
    Cai TQ; Wu W; Shin MK; Xu Y; Jochnowitz N; Zhou Y; Hoos L; Bentley R; Strapps W; Thankappan A; Metzger JM; Ogletree ML; Tadin-Strapps M; Seiffert DA; Chen Z
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):893-902. PubMed ID: 26192114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contact system in liver injury.
    Rangaswamy C; Mailer RK; Englert H; Konrath S; Renné T
    Semin Immunopathol; 2021 Aug; 43(4):507-517. PubMed ID: 34125270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Factor XII in hemostasis and thrombosis: clinical implications.
    Renné T; Gailani D
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI.
    Kearney KJ; Butler J; Posada OM; Wilson C; Heal S; Ali M; Hardy L; Ahnström J; Gailani D; Foster R; Hethershaw E; Longstaff C; Philippou H
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33397811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.